RAVLT delayed recall

Biomarker

7 papers3 findings

  • Human trial1
  • Humans6

Upstream

1

Total tau

no changein humans1

1 study
  1. Total tau has no effect on RAVLT delayed recall in humans (γ2 = -0.002, p = .09).

    “Baseline CSF t‐tau level did not predict two‐year RAVLT DR changes ( γ2 =‐0.002, z ‐score=‐1.4, p =.09).”

    Humanscognitively healthy older adults2 yearsn = 149

    RAVLT Delayed Recall predicts two‐year changes in cerebrospinal fluid total‐tau for cognitively healthy older adults

    AAIC 2025 abstract23 Dec 2025

More on Total tau

Associations

2

T-tau/Aβ42 ratio

downin humans1

1 study
  1. RAVLT delayed recall predicts T-tau/Aβ42 ratio in humans (γ1 = -0.01, p = 0.036).

    “Baseline delayed recall scores were negatively associated with a two‐year change in the CSF t‐tau/Aβ 1‐42 ratio (γ1 = ‐0.01, z = 0.0068, p = 0.036).”

    Humans2 yearsn = 92

    Delayed recall predicts change in cerebrospinal fluid biomarkers over two years

    AAIC 2025 abstract26 Dec 2025

More on T-tau/Aβ42 ratio

Total tau

downin humans1

1 study
  1. RAVLT delayed recall predicts total tau in humans (γ1 = -8.9, p = .014).

    “Baseline RAVLT DR scores predicted two‐year t‐tau change ( γ1 =‐8.9, z ‐score=‐2.2, p =.014)”

    Humanscognitively healthy older adults2 yearsn = 149

    RAVLT Delayed Recall predicts two‐year changes in cerebrospinal fluid total‐tau for cognitively healthy older adults

    AAIC 2025 abstract23 Dec 2025

More on Total tau

Latest

Nov 2025: 0Dec 2025: 8Jan 2026: 2Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 011 in 12 months